Call our 24 hours, seven days a week helpline at 800.272.3900

24/7 Helpline 800.272.3900
Donate
Greater Pennsylvania
Change Location

Alzheimer’s Drug on CMS Funding Chopping Block

Alzheimer’s Drug on CMS Funding Chopping Block
Share or Print this page
Share or Print this page
February 9, 2022
Email:
Share or Print this page

Alzheimer’s Drug on CMS Funding Chopping Block

Many Alzheimer’s patients who rely on a certain type of drug for treatment are in danger of losing federal insurance coverage to fund the cost. Eyewitness News has done several reports on that drug, Aducanumab. The FDA approved it last June but now it could be on the Medicare and Medicaid coverage chopping block.

Watch the story from WBRE-TV in Wilkes-Barre, PA at the link above to learn more about the impact the draft decision could have.

Alzheimer's Association

The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia.™ For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.

Keep Up With Alzheimer’s News and Events

The first survivor of Alzheimer's is out there, but we won't get there without you.

Donate Now

Learn how Alzheimer’s disease affects the brain.

Take the Brain Tour

Don't just hope for a cure. Help us find one. Volunteer for a
clinical trial.

Learn More